Skip to main content
Erschienen in: Drugs & Aging 2/2000

01.02.2000 | Leading Article

Photodynamic Therapy in Gastrointestinal Cancer

A Realistic Option?

verfasst von: Professor Hugh Barr

Erschienen in: Drugs & Aging | Ausgabe 2/2000

Einloggen, um Zugang zu erhalten

Abstract

Photodynamic therapy is now a useful and practical option of the local treatment of gastrointestinal cancers. There is increasing screening and surveillance of patients at risk of oesophageal and gastric cancers. The early detection of disease is often unhelpful if an elderly or frail patient needs to be subjected to radical resectional surgery. Photodynamic therapy can eradicate and cure early mucosal disease following a single endoscopic treatment. If the disease is more advanced good local control and palliation is often possible. Overall, palliation can often be achieved using simpler methods which are highly effective and not associated with the problems of prolonged photosensitisation. It is rapidly becoming clear that the ideal indication is for the treatment of dysplastic lesions in the oesophagus associated with columnar-lined oesophagus (Barrett’s oesophagus). In these circumstances a heterogeneous field change often with multifocal dysplasia or cancer can be widely eradicated. Similar areas of squamous dysplasia in the upper oesophagus can be treated. At present a major complication of stricture formation is associated with the use of some photosensitisers. The treatment of cancer at the ampulla of Vater and choriocarcinoma is also proving very effective. The treatment can be performed at endoscopy and is well tolerated and safe.
Literatur
1.
Zurück zum Zitat Grant WE, Hopper C, MacRobert AJ, et al. Photodynamic therapy of oral cancer: photosensitisation with systemic aminolaevulinic acid. Lancet 1993; 342: 147–8PubMedCrossRef Grant WE, Hopper C, MacRobert AJ, et al. Photodynamic therapy of oral cancer: photosensitisation with systemic aminolaevulinic acid. Lancet 1993; 342: 147–8PubMedCrossRef
2.
Zurück zum Zitat Barr H, Tralau CJ, Boulos PB, et al. Selective destruction of dimethyl-hydrazine rat colon cancer using phthalocyanine photodynamic therapy. Gastroenterology 1990; 98: 1532–7PubMed Barr H, Tralau CJ, Boulos PB, et al. Selective destruction of dimethyl-hydrazine rat colon cancer using phthalocyanine photodynamic therapy. Gastroenterology 1990; 98: 1532–7PubMed
3.
Zurück zum Zitat Gossner L, Stolte M, Sroka R, et al. Photodynamic ablation of high grade dysplasia and early cancer in Barrett’s esophagus by means of 5-amiolevulinic acid. Gastroenterology 1998; 114: 447–55CrossRef Gossner L, Stolte M, Sroka R, et al. Photodynamic ablation of high grade dysplasia and early cancer in Barrett’s esophagus by means of 5-amiolevulinic acid. Gastroenterology 1998; 114: 447–55CrossRef
4.
Zurück zum Zitat Heier SK, Rothman KA, Heier LM, et al. Photodynamic therapy for obstructing esophageal cancer: light dosimetry and randomized comparison with Nd: YAG laser therapy. Gastroenterology 1995; 109: 63–72PubMedCrossRef Heier SK, Rothman KA, Heier LM, et al. Photodynamic therapy for obstructing esophageal cancer: light dosimetry and randomized comparison with Nd: YAG laser therapy. Gastroenterology 1995; 109: 63–72PubMedCrossRef
5.
Zurück zum Zitat Barr H, Krasner N, Boulos PB, et al. Photodynamic therapy for colorectal cancer: a quantitative pilot study. Br J Surg 1990; 77: 93–6PubMedCrossRef Barr H, Krasner N, Boulos PB, et al. Photodynamic therapy for colorectal cancer: a quantitative pilot study. Br J Surg 1990; 77: 93–6PubMedCrossRef
6.
Zurück zum Zitat Tan WC, Shepherd NA, Roberts DJH, et al. Photodynamic therapy using 5-aminolaevulinic acid for oesophageal adenocarcinoma associated with Barrett’s metaplasia. J Photochem Photobiol B: Biology. In press Tan WC, Shepherd NA, Roberts DJH, et al. Photodynamic therapy using 5-aminolaevulinic acid for oesophageal adenocarcinoma associated with Barrett’s metaplasia. J Photochem Photobiol B: Biology. In press
7.
Zurück zum Zitat Lightdale CJ, Heier SK, Marcon NE, et al. Photodynamic therapy with porfimer sodium versus thermal ablation with Nd: YAG laser for palliation of esophageal cancer: a multicentre randomized trial. Gastrointest Endosc 1995; 42: 507–12PubMedCrossRef Lightdale CJ, Heier SK, Marcon NE, et al. Photodynamic therapy with porfimer sodium versus thermal ablation with Nd: YAG laser for palliation of esophageal cancer: a multicentre randomized trial. Gastrointest Endosc 1995; 42: 507–12PubMedCrossRef
8.
Zurück zum Zitat Sibille A, Lambert R, Souquet JC, et al. Long-term survival after photodynamic therapy for esophageal cancer. Gastroenterology 1995; 108: 337–44PubMedCrossRef Sibille A, Lambert R, Souquet JC, et al. Long-term survival after photodynamic therapy for esophageal cancer. Gastroenterology 1995; 108: 337–44PubMedCrossRef
9.
Zurück zum Zitat Overholt BF, Panjepour M, Haydek JM. Photodynamic therapy for Barrett’s esophagus: follow-up in 100 patients. Gastrointest Endosc 1999; 49: 1–7PubMedCrossRef Overholt BF, Panjepour M, Haydek JM. Photodynamic therapy for Barrett’s esophagus: follow-up in 100 patients. Gastrointest Endosc 1999; 49: 1–7PubMedCrossRef
10.
Zurück zum Zitat Hayata Y, Kato H, Furuse K, et al. Photodynamic therapy of 168 early stage cancers of the lung and oesophagus: a Japanese multicentre study. Lasers Med Sci 1996; 11: 255–9CrossRef Hayata Y, Kato H, Furuse K, et al. Photodynamic therapy of 168 early stage cancers of the lung and oesophagus: a Japanese multicentre study. Lasers Med Sci 1996; 11: 255–9CrossRef
11.
Zurück zum Zitat Grosjean P, Savary J-F, Wagnieres G, et al. Tetra(m-hydroxyphenyl)chlorin clinical photodynamic therapy of early bronchial and oesophageal cancers. Lasers Med Sci 1996; 11: 227–35CrossRef Grosjean P, Savary J-F, Wagnieres G, et al. Tetra(m-hydroxyphenyl)chlorin clinical photodynamic therapy of early bronchial and oesophageal cancers. Lasers Med Sci 1996; 11: 227–35CrossRef
12.
Zurück zum Zitat Barr H, Tralau CJ, Boulos PB, et al. The contrasting mechanisms of colonic damage between photodynamic therapy and thermal injury. Photochem Photobiol 1987; 46: 795–800PubMedCrossRef Barr H, Tralau CJ, Boulos PB, et al. The contrasting mechanisms of colonic damage between photodynamic therapy and thermal injury. Photochem Photobiol 1987; 46: 795–800PubMedCrossRef
13.
Zurück zum Zitat Ell C, Gossner L, May A, et al. Photodynamic ablation of early cancers of the stomach by means of mTHPC and laser irradiation: preliminary clinical experience. Gut 1998; 43: 345–9PubMedCrossRef Ell C, Gossner L, May A, et al. Photodynamic ablation of early cancers of the stomach by means of mTHPC and laser irradiation: preliminary clinical experience. Gut 1998; 43: 345–9PubMedCrossRef
14.
Zurück zum Zitat Schlemper RJ, Itabashi M, Kato Y, et al. Differences in diagnostic criteria for gastric carcinoma between Japanese and Western pathologists. Lancet 1997: 349; 1725–9PubMedCrossRef Schlemper RJ, Itabashi M, Kato Y, et al. Differences in diagnostic criteria for gastric carcinoma between Japanese and Western pathologists. Lancet 1997: 349; 1725–9PubMedCrossRef
15.
Zurück zum Zitat Barr H, Shepherd NA, Dix A, et al. Eradication of high-grade dysplasia in columnar-lined (Barrett’s) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX. Lancet 1996; 348: 584–5PubMedCrossRef Barr H, Shepherd NA, Dix A, et al. Eradication of high-grade dysplasia in columnar-lined (Barrett’s) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX. Lancet 1996; 348: 584–5PubMedCrossRef
16.
Zurück zum Zitat Grosjean P, Monnier P. Photodynamic therapy and mucosectomy for early squamous cell carcinomas in the oesophagus and tracheobronchial tree [abstract]. Eur J Surg Oncol 1998; 24: 234 Grosjean P, Monnier P. Photodynamic therapy and mucosectomy for early squamous cell carcinomas in the oesophagus and tracheobronchial tree [abstract]. Eur J Surg Oncol 1998; 24: 234
17.
Zurück zum Zitat Ortner MAEJ, Liebetruth J, Schreiber S, et al. Photodynamic therapy of nonresectable cholangiocarcinoma. Gastroenterology 1998; 114: 536–42PubMedCrossRef Ortner MAEJ, Liebetruth J, Schreiber S, et al. Photodynamic therapy of nonresectable cholangiocarcinoma. Gastroenterology 1998; 114: 536–42PubMedCrossRef
18.
Zurück zum Zitat Abulafi AM, Allardice JT, Williams NS, et al. Photodynamic therapy for malignant tumours of the ampulla of Vater. Gut 1995; 36: 853–6PubMedCrossRef Abulafi AM, Allardice JT, Williams NS, et al. Photodynamic therapy for malignant tumours of the ampulla of Vater. Gut 1995; 36: 853–6PubMedCrossRef
19.
Metadaten
Titel
Photodynamic Therapy in Gastrointestinal Cancer
A Realistic Option?
verfasst von
Professor Hugh Barr
Publikationsdatum
01.02.2000
Verlag
Springer International Publishing
Erschienen in
Drugs & Aging / Ausgabe 2/2000
Print ISSN: 1170-229X
Elektronische ISSN: 1179-1969
DOI
https://doi.org/10.2165/00002512-200016020-00001

Weitere Artikel der Ausgabe 2/2000

Drugs & Aging 2/2000 Zur Ausgabe

New Drug Profile

Verteporfin

New Drug Profile

Verteporfin

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.